Table 1. Immunization regimen and the frequency of SIV antigen specific IFN-γ spot-forming cells.
Group | Immunization | Dosagea | Spot-forming cells for structural antigens | Spot-forming cells for non-structural antigens |
---|---|---|---|---|
1 | rAd5-empty | 1.0 × 1010 vp | 53 ± 24 | 21 ± 5 |
2 | rAd5-SIV | 0.5 × 1010 vp | 342 ± 38 | 2 ± 1 |
3 | rAd5-SIV + | 0.5 × 1010 vp | 1068 ± 72 | 25 ± 4 |
rAd5-sPD1 | 0.25 × 1010 vp | |||
4 | rAd5-SIV + | 0.5 × 1010 vp | 564 ± 31 | 5 ± 2 |
rAd5-sTim3 | 0.25 × 1010 vp | |||
5 | rAd5-SIV + | 0.5 × 1010 vp | 1801 ± 64 | 175 ± 18 |
rAd5-sPD1 + rAd5-sTim3 |
0.25 × 1010 vp 0.25 × 1010 vp |
a rAd5 vectors at 1 × 1010 viral particles (vp) final dose were used to immunized mice. rAd5-empty was used to make up the final dose (0.5 × 1010 vp for group 2 and 0.25 × 1010 vp for groups 3 and 4).